11 Iconic Perfumes of the 1980s
There was nothing understated about the ’80s—and that included the most popular perfumes of the decade.
2023-05-23 03:17
Nebraska GOP senator who voted for anti-trans and anti-abortion bill that passed by one vote admits she didn’t pay attention to the issue
A Nebraska Republican state senator who voted for a combined anti-trans and anti-abortion bill that passed by one vote in the legislature has admitted that she didn’t pay attention to the issue. State Senator Christy Armendariz represents the 18th District in the state. Writing for New York magazine, journalist Lila Shapiro said that the senator “led me to a bench in an empty hallway” to say that she “found it puzzling that a reporter from New York would come all the way to Nebraska to cover this affair”. “I don’t watch the news or get the newspaper,” she told the magazine. “Is there anything going on I should be aware of?” The writer told Ms Armendariz that other states have passed other similar bills restricting trans and women’s reproductive rights and that an appeals court on the federal level in the Nebraska circuit had ruled that one of them was unconstitutional. “So is it a big widespread thing?” she asked the writer, adding that regular Nebraska residents were unaware of the issue. “I knocked doors for a year, and nobody brought this up,” the senator said, adding that she wished that the legislation had never been brought to the floor. For three months, a group of lawmakers in the state has ground nearly all legislative business in the state to a halt, grabbing the nation’s attention with a remarkable filibuster to stifle a bill that would end gender-affirming care for young transgender people. Late Tuesday 16 May, Republican lawmakers broke through, advancing a bill that not only bans gender-affirming care for trans people under 19 years old but also tacks on an amendment to outlaw abortion after 10 weeks of pregnancy and hands the state’s GOP-appointed medical officer the authority to set the rules for affirming care for trans youth. Hundreds of protesters filled the capital in Lincoln, standing outside the doors and in the gallery above lawmakers while chanting “one more vote to save our lives”; only one senator would have had to defect from supporters of the bill to kill the legislation. The vote – on the 78th day of a 90-day session – followed a series of manoeuvres that opponents argued were bending and breaking the rules of the state legislature to hammer through the legislation and avert the filibuster, which would allow opponents to occupy their allotted time to speak the bill to death. “What you are attempting to do today is the lowest of the absolute lows,” state Senator Machaela Cavanaugh, who spearheaded the filibuster, told Republican lawmakers. “You literally have to cheat at every moment of this debate in every possible way … You are allowing it to happen,” she added. “You do literally have blood on your hands, and if you vote for it, you will have buckets.” State Senator Megan Hunt, the first openly LGBT+ member of the state legislature and the mother of a trans child, lambasted lawmakers for their “escape routes” from the capitol to avoid facing protesters. “If you can’t go out and face them, you are not worthy,” she said. “Your legacy is filth.” Protesters surrounded the state capitol chambers in Lincoln on 19 May chanting “keep your bans off our bodies” and “save our lives” as lawmakers made their final round of votes on the bill, which passed 33-15, according to Reuters. The bill reached the exact number of votes needed to pass. Republican Governor Jim Pillen signed it into law on Monday. Before signing the bill, Mr Pillen said, “We are working to inspire Nebraskans to get in the game so that abortion is simply unthinkable in the state of Nebraska,” according to WOWT. He added that it was “an extremely historic day for Nebraska. It’s a day where it’s really simple: We’re standing up to protect our kids so our state has a bigger and brighter future. LB574 is the most significant win for [the] social conservative agenda that over a generation has seen in Nebraska. I think that’s something we need to clap and shout about”. At a show in Nebraska hours after the vote on Friday night, the artist Lizzo lambasted the legislation from the stage. “It really breaks my heart that there are young people growing up in a world that doesn’t protect them,” she said. “Don’t let anyone tell you who you are. ... These laws are not real. You are what’s real, and you deserve to be protected.” Ari Kohen, a political science professor at the University of Nebraska–Lincoln, tweeted: “Hat tip to Senator Armendariz, who says she doesn’t know anything about the issue, doesn’t pay attention to current events, and wishes the bill she voted for hadn’t been introduced. It passed by 1 vote.” “These are the people who devoted an entire legislative session to taking away people’s rights in the face of massive opposition from experts and ordinary citizens. They openly admit that none of their constituents mentioned this issue to them and they don’t know much about it,” he added. “We have a handful of legislators who care enough to listen and learn. And then we have the majority, who seem not to know or care what they’re doing as long as it feels right to them and they have the votes to do it. Awful.” Journalist and author Charles Jaco tweeted that a similar assessment could be made regarding the Missouri legislature. “You have a handful of lawmakers who are serious, substantial people. The rest are various shades of know-nothing religious fanatics, grifters, and bigoted buffoons,” he tweeted. The Independent has reached out to Ms Armendariz for comment. Read More Nebraska governor to sign 12-week abortion ban, limits on gender-affirming care for minors Lizzo blasts Nebraska bill banning abortion access and gender-affirming care: ‘You deserve to be protected’ Here are the restrictions on transgender people that are moving forward in US states Nebraska governor to sign 12-week abortion ban, limits on gender-affirming care for minors Lizzo blasts Nebraska bill banning abortion access and gender-affirming care Nebraska expected to pass 12-week abortion ban, restrictions on gender-affirming care
2023-05-23 03:15
The Reason Your Dog Follows You Everywhere
If your dog follows everywhere you go, don’t be too worried about it. The behavior indicates they see you in a positive light.
2023-05-23 01:27
7 Facts About Joyce Chen, the TV Chef Who Introduced Americans to Chinese Cuisine
Through her restaurant, cookbook, and television show, Joyce Chen introduced many Americans to Chinese cuisine.
2023-05-23 00:19
Carmelo Anthony, 10-time NBA All-Star and one of basketball's greatest scorers, announces retirement
Carmelo Anthony, one of the greatest scorers the NBA has ever seen, has announced his retirement from basketball at the age of 38.
2023-05-22 23:58
Supreme Court ducks fight over foie gras, leaving California ban in place
Canadian duck and goose farmers call the controversial delicacy the most "maligned and misunderstood food in the world."
2023-05-22 23:27
Former soldier who lost both legs in Afghanistan makes history on Everest
A former soldier who lost both his legs in an explosion in Afghanistan has made history by conquering Everest.
2023-05-22 23:16
What is fezolinetant? The non-hormonal menopause treatment drug explained
The menopause treatment fezolinetant has been predicted as a “gamechanger” by experts for thousands of women who suffer from hot flushes. The drug, which is the first non-hormonal menopause treatment, was recently approved by America’s FDA. Experts are predicting it could be transformative for women for whom hormone replacement drugs (HRT) are not suitable. The drug was licensed in the US on 12 May and could be approved for use in the UK by the end of the year. According to a British Menopause Society survey, 79 per cent of women aged 45 to 65 experienced hot flushes as a result of their menopause transition, while 10 to 20 per cent describe the hot flushes as “near intolerable”. Here’s everything you need to know about fezolinetant: What is it used to treat? It works to target the menopause symptom of hot flushes. The drug that has been approved by the FDA is made by pharmaceutical company Astella, which advises patients to take one 45-milligram of its VEZOAH (fezolinetant) pill orally, once a day. A large clinical trial of fezolinetant published earlier this year revealed that, after 12 weeks of use, it reduced the frequency of hot flushes by about 60 per cent in women with moderate or severe symptoms, in comparison to a 45 per cent reduction in those who received a placebo. Women involved in the trial also said the drug reduced the severity of hot flushes and improved the quality of their sleep. How does it work? It works by blocking a brain protein called neurokinin-3, which plays a unique role in regulating body temperature in menopausal women. Respondents of the trial have said that the effects of the drug was experienced after taking the first tablet. By comparison, HRT, taken to alleviate menopausal symptoms, replaces the oestrogen that you lose during the menopause transition, either alone or in combination with a progestogen What are the side effects? According to the FDA, the most common side effects are abdominal pain, diarrhoea, insomnia, back pain, hot flush and elevated hepatic transaminases. What have experts said about it? “This is going to be a completely blockbuster drug,” said Prof Waljit Dhillo, an endocrinologist at Imperial College London who led a trial for the drug in 2017 toldThe Guardian. “It’s like a switch. Within a day or two the flushes go away. It’s unbelievable how well these drugs work. It’s going to be completely game changing for a lot of women.” Read More Adenomyosis: 5 things you need to know about the ‘evil twin sister’ of endometriosis ‘Suddenly, I saw Dad again’: The radical technology helping those living with dementia Naga Munchetty reveals womb condition adenomyosis: ‘I live every day on painkillers’
2023-05-22 21:29
Can Beer Convince Americans to Drink Recycled Wastewater?
Earlier this year, a new beer appeared on the menu at Fox City Brewing Company in Forsyth, Georgia.
2023-05-22 20:55
25 Years Later: The History of Unreal and an Epic Dynasty
When you start a software company, you never know where it’s going to lead. For
2023-05-22 20:29
Adenomyosis: 5 things you need to know about the ‘evil twin sister’ of endometriosis
Despite increasing public awareness of endometriosis, with celebrity figureheads including Lena Dunham and Molly Mae, the condition’s ‘evil twin sister’, adenomyosis, remains neglected. While the NHS has an entire webpage which explains what endometriosis is, there is currently no equivalent for its sister condition. Read on for five things you should know. It’s not the same as endometriosis Both endometriosis and adenomyosis occur when the lining of the uterus (known as the endometrium) grows out of place, but there are major differences between the two. In endometriosis, the rogue tissue invades areas outside of the uterus. While the extent of the growth varies from patient to patient, it can affect areas such as the bladder, bowel, ovaries, and even the lungs. Adenomyosis, on the other hand, causes the rogue tissue to bury inside the muscular wall of the uterus. It’s possible to suffer from both conditions at the same time. Symptoms include bloating, heavy periods, and pelvic pain Thanks to the invasive endometrial growth, adenomyosis is characterised by an enlarged uterus. During menstruation, the embedded tissue swells and bleeds, typically causing a variety of symptoms (although some women are asymptomatic). According to a patient leaflet published by University College Hospital, sufferers commonly have painful and irregular periods, with more than half experiencing heavy bleeding. Chronic pre-menstrual pain, and feelings of heaviness and discomfort in the pelvis are among other possible symptoms. Less frequently, adenomyosis can cause bloating, pain during intercourse, and pain related to bowel movements. All symptoms should stop after the menopause. It affects 1 in 10 women The condition is believed to affect 10 per cent of women in the UK. That makes it just as prevalent as endometriosis, although it’s more common in women between the ages of 40-50, and those who have been pregnant before. While the cause of the condition is not known, UCH says that “genetics and some hormones may play a role”. In terms of long-term effects, the North Bristol NHS trust says that adenomyosis does not appear to decrease the chance of pregnancy, however it has been linked to an increased risk of miscarriage and premature birth. Treatment options are limited For women with mild symptoms, trying to get pregnant, or nearing menopause, the North Bristol trust says that treatment may not be necessary, but for those seeking relief from symptoms, it recommends medication to reduce pain and bleeding, and hormonal interventions such as the contraceptive pill. The only “cure” is a surgical procedure involving the removal of the womb (hysterectomy), although this is a last resort intervention. The Bristol-based trust also offers an alternative surgery which involves blocking the blood supply to the endometrial growth, forcing it to shrink, but neither procedure is advisable for women who want to get pregnant in the future. It can take years to diagnose The condition is typically diagnosed using MRI and ultrasound scans, but the NHS says that adenomyosis can take “a long time, even years, to diagnose” because “symptoms and severity can vary between women”. The frequent dismissal of women’s gynaecological symptoms means that signs of adenomyosis may be conflated with ‘normal’ menstruation, or even other conditions such as endometriosis. Anecdotal reports of sufferers suggest that misdiagnosis is common. Gabrielle Union, one of the only celebrities to have publicly identified as having the condition, suspects her condition went undiagnosed for years. Speaking at a conference in 2019, Union explained: “The gag is I had [adenomyosis] in my early twenties, and instead of someone diagnosing me they were like ‘Oh you have periods that last nine or 10 days and you’re bleeding through overnight pads? Not a mere inconvenience... perhaps there’s something more there.’” Earlier this year, the charity Tommy’s reported that the condition might be “underdiagnosed” after a review of existing studies found that “mild” cases could be missed by clinicians using current diagnostic methods. “There should be training for clinicians and sonographers to diagnose adenomyosis using a standardised criteria,” said Dr Ishita Mishra, leader of the review. “Being able to identify this condition using a uniform set of criteria would then help give us a true picture of the numbers affected, and better understanding of the impact of this condition,” Mishra explained. If you have any health concerns, you should always contact your GP in the first instance. There is also information available via NHS Scotland or Endometriosis UK. Read More Lena Dunham marks five years of sobriety: ‘Happiest of my time on earth’ ‘Some days things just do not work’: What happens when your smear test doesn’t go smoothly? Woman’s warning after terminal cancer mistaken for heavy periods 5 things you need to know about adenomyosis, the ‘evil twin sister’ of endometriosis Woman’s warning after lip filler left her unable to close mouth ‘Suddenly, I saw Dad again’: The radical tech helping those living with dementia
2023-05-22 19:45
Mount Etna eruption grounds flights in Sicily with clouds of ash
Flights from Catania airport in Sicily were grounded on Sunday after volcanic ash from an eruption of Mount Etna covered the runways.
2023-05-22 19:19